PillSodium Bicarbonate
Sodium Bicarbonate
17 active makers
soon
soon
soon
soon
US acquisition costNADAC · per unit
Average across 8 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
Who makes it17 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Exela Pharma Sciences, LLC | unknown | 6 | SUPPLYING |
| Medical Purchasing Solutions, LLC | unknown | 5 | SUPPLYING |
| Hospira, Inc. | unknown | 5 | SUPPLYING |
| HF Acquisition Co LLC, DBA HealthFirst | unknown | 5 | SUPPLYING |
| Bryant Ranch Prepack | repackager | 2 | SUPPLYING |
| Fresenius Kabi USA, LLC | unknown | 2 | SUPPLYING |
| Omnivium Pharmaceuticals LLC | unknown | 2 | SUPPLYING |
| Anthea Pharma Private Limited | unknown | 2 | SUPPLYING |
| A-S Medication Solutions | unknown | 2 | SUPPLYING |
| Henry Schein Inc. | unknown | 2 | SUPPLYING |
| Amneal Pharmaceuticals Private Limited | unknown | 2 | SUPPLYING |
| STERISCIENCE SPECIALTIES PRIVATE LIMITED | unknown | 1 | SUPPLYING |
| Long Grove Pharmaceuticals, LLC | unknown | 1 | SUPPLYING |
| Glenmark Pharmaceuticals Inc., USA | unknown | 1 | SUPPLYING |
| SUN PHARMACEUTICAL INDUSTRIES, INC. | unknown | 1 | SUPPLYING |
+ 2 more labelers
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Aug 4, 2025RECALLRecall (Class II): Vial Label: 8.4% Sodium Bicarbonate Injection, USP, 50mEq/50 mL (1 mEq/mL), Rx only, Hospira, Inc., Lake Forest, IL 600…
Lack of Assurance of Sterility. — Recalling firm: PFIZER INC — U.S. Nationwide
- Jul 30, 2025RECALLRecall (Class II): 4.2% Sodium Bicarbonate Injection, USP, 5 mEq/10 mL (0.5 mEq/mL), For Intravenous Use Only, 10 mL Single Dose Vial, Rx …
Failed Impurities/Degradation Specifications: out of specification results for arsenic in the impurities tested. — Recalling firm: Exela Pharma Sciences LLC — Nationwide in the USA
- Mar 7, 2025RECALLRecall (Class II): 8.4% Sodium Bicarbonate Injection, USP, 50 mEq/50 mL (1 mEq/mL), 25 x 50 mL Single Dose Vials per carton, For Intraveno…
Lack of Assurance of Sterility — Recalling firm: Exela Pharma Sciences LLC — Nationwide
- Dec 21, 2023RECALLRecall (Class I): 8.4 % Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL), Lifeshield, Glass ABBOJECT Unit of Use Syringe, Rx Onl…
Presence of Particulate Matter; identified as glass — Recalling firm: Pfizer Inc. — Nationwide in the USA and Puerto Rico.
- Oct 18, 2023RECALLRecall (Class I): 8.4% Sodium Bicarbonate Injection, USP, 50 mEq/50 mL (1mEq/mL), a) 20x50 mL Single Dose Vials (Vial NDC 51754-5001-1; C…
Presence of Particulate Matter: Silicone — Recalling firm: Exela Pharma Sciences LLC — Nationwide
- Nov 28, 2022RECALLRecall (Class I): 8.4% Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL) 50 mL Single Dose Vials, packaged in cartons of 20 vials…
Defective Container: Complaints received of vial breakage and glass flying when pressurized while preparing the product for administration. — Recalling firm: Exela Pharma Sciences LLC — Nationwide within the United States
- Oct 4, 2022RECALLRecall (Class I): 8.4% Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL) 50 mL Single Dose Vials, packaged in cartons of 20 vials…
Defective Container: Complaints received of vial breakage and glass flying when pressurized while preparing the product for administration — Recalling firm: Exela Pharma Sciences LLC — Nationwide within the United States
- Jul 24, 2017SHORTAGEDrug shortage: Sodium Bicarbonate Injection (Exela Pharma Sciences, LLC)
Sodium Bicarbonate Injection — reported in shortage by Exela Pharma Sciences, LLC. Therapeutic category: Endocrinology/Metabolism, Gastroenterology, Pediatric.
- Jul 24, 2017SHORTAGEDrug shortage: Sodium Bicarbonate Injection (Fresenius Kabi USA, LLC)
Sodium Bicarbonate Injection — reported in shortage by Fresenius Kabi USA, LLC. Therapeutic category: Endocrinology/Metabolism, Gastroenterology, Pediatric.
- Mar 1, 2017SHORTAGEDrug shortage: Sodium Bicarbonate Injection (Long Grove Pharmaceuticals LLC)
Sodium Bicarbonate Injection — reported in shortage by Long Grove Pharmaceuticals LLC. Therapeutic category: Endocrinology/Metabolism, Gastroenterology, Pediatric.
- Mar 1, 2017SHORTAGEDrug shortage: Sodium Bicarbonate Injection (Hospira, Inc., a Pfizer Company)
Sodium Bicarbonate Injection — reported in shortage by Hospira, Inc., a Pfizer Company. Therapeutic category: Endocrinology/Metabolism, Gastroenterology, Pediatric.